AIM ImmunoTech converts $400,000 of Streeterville note into 1,749,434 shares
AIM ImmunoTech Inc. exchanged approximately $400,000 of a November 18, 2025 promissory note held by Streeterville Capital, LLC into 1,749,434 shares of common stock at an average conversion price of about $0.228 per share. The transactions were carried out through two exchange agreements signed September 8 to September 9, 2026, and the shares were issued under a Securities Act exemption for exchanges with an existing holder. Because the new shares add to the outstanding share count, existing shareholders' ownership percentages are diluted, although the filing does not state the total share count.
Key points
- Debt converted: approximately $400,000 of the Promissory Note dated November 18, 2025
- Shares issued: 1,749,434 shares of common stock at an average conversion price of about $0.228 per share
- Agreements dated September 8 to September 9, 2026, with Streeterville Capital, LLC; stockholders approved the conversion at a July 15, 2026 special meeting
- Shares issued under Section 3(a)(9) of the Securities Act, with no commission paid for the exchange
The filing
Written by AI on Nov 9, 2026, 8:29 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 14, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.